Qube Research & Technologies LTD Biomarin Pharmaceutical Inc Transaction History

Qube Research & Technologies LTD

$62.3 Billion
Q2 2024

A detailed history of Qube Research & Technologies LTD transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 14 shares of BMRN stock, worth $989. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 12,100 99.88%

Holding current value

$989

Previous $1.06 Million 99.91%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$74.43 - $92.22 $1.1 Million - $1.37 Million	-14,835 Reduced 99.91%	14 $1,000
Q1 2024 May 14, 2024	BUY	$83.81 - $99.0 $361,975 - $427,581	4,319 Added 41.02%	14,849 $1.3 Million
Q4 2023 Feb 13, 2024	SELL	$76.22 - $98.51 $5.42 Million - $7.01 Million	-71,145 Reduced 87.11%	10,530 $1.02 Million
Q3 2023 Nov 13, 2023	SELL	$85.07 - $94.48 $34.7 Million - $38.5 Million	-407,530 Reduced 83.3%	81,675 $7.23 Million
Q2 2023 Aug 14, 2023	BUY	$86.68 - $100.3 $1.08 Million - $1.25 Million	12,454 Added 2.61%	489,205 $42.4 Million
Q1 2023 May 15, 2023	BUY	$87.74 - $117.27 $18.6 Million - $24.8 Million	211,481 Added 79.72%	476,751 $46.4 Million
Q4 2022 Feb 14, 2023	BUY	$80.93 - $108.63 $13.8 Million - $18.5 Million	169,933 Added 178.24%	265,270 $27.5 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $7.83 Million - $9.24 Million	95,337 New	95,337 $8.08 Million
Q2 2022 Aug 15, 2022	SELL	$71.48 - $86.85 $19.2 Million - $23.3 Million	-268,780 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$74.28 - $92.69 $20 Million - $24.9 Million	268,780 New	268,780 $20.7 Million
Q4 2021 Feb 01, 2022	SELL	$71.72 - $91.47 $1.74 Million - $2.21 Million	-24,205 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$74.77 - $85.47 $766,542 - $876,238	10,252 Added 73.48%	24,205 $1.87 Million
Q2 2021 Aug 13, 2021	BUY	$75.51 - $84.79 $241,405 - $271,073	3,197 Added 29.72%	13,953 $1.16 Million
Q1 2021 May 14, 2021	BUY	$74.73 - $90.69 $803,795 - $975,461	10,756 New	10,756 $812,000
Q4 2020 Feb 16, 2021	SELL	$72.61 - $90.2 $3.78 Million - $4.7 Million	-52,118 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$71.87 - $131.03 $3.3 Million - $6.02 Million	45,906 Added 738.99%	52,118 $3.97 Million
Q2 2020 Aug 14, 2020	BUY	$79.55 - $124.22 $494,164 - $771,654	6,212 New	6,212 $766,000
Q3 2019 Nov 13, 2019	SELL	$67.4 - $85.11 $430,483 - $543,597	-6,387 Closed	0 $0
Q2 2019 Aug 02, 2019	BUY	$80.35 - $93.9 $187,536 - $219,162	2,334 Added 57.59%	6,387 $547,000
Q1 2019 May 15, 2019	BUY	$84.2 - $98.62 $341,262 - $399,706	4,053 New	4,053 $360,000
Q4 2018 Feb 14, 2019	SELL	$80.14 - $106.07 $216,698 - $286,813	-2,704 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$93.92 - $105.72 $253,959 - $285,866	2,704 New	2,704 $262,000

Others Institutions Holding BMRN

# of Institutions

632

Shares Held

185M

Call Options Held

1.63M

Put Options Held

1.2M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Biomarin Pharmaceutical Inc Transaction History